Wanhai Xu
Impact in
- Biomaterials top 2%
- Supramolecular Self-Assembly in Materials
- Nanoparticle-Based Drug Delivery
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Epigenetics and DNA Methylation 7
-
- Prostate Cancer Treatment and Research 10
- Renal cell carcinoma treatment 9
- Co-authors
- Da‐Yong Hou (36 shared papers)Hao Wang (29 shared papers)Man‐Di Wang (13 shared papers)Keliang Wang (5 shared papers)Dong‐Bing Cheng (6 shared papers)Zeng‐Ying Qiao (4 shared papers)Hong‐Wei An (9 shared papers)Hongtao Lu (2 shared papers)
- Journals
- Nature Communications (6 papers)Advanced Materials (6 papers)Small (5 papers)Biomaterials (5 papers)Scientific Reports (4 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Wanhai Xu
128 papers receiving 3.4k citations
Wanhai Xu's Hit Papers
Peers
Comparison fields: 5 of 121
- Biomaterials 659
- Cancer Research 614
- Molecular Biology 1.6k
- Biomedical Engineering 868
- Oncology 439
Countries citing papers authored by Wanhai Xu
This map shows the geographic impact of Wanhai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanhai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanhai Xu more than expected).
Fields of papers citing papers by Wanhai Xu
This network shows the impact of papers produced by Wanhai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanhai Xu. The network helps show where Wanhai Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanhai Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 134 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 212 | |
| 2 | 2019 | 185 | |
| 3 | 2019 | 170 | |
| 4 | 2019 | 145 | |
| 5 | 2013 | 122 | |
| 6 | 2019 | 110 | |
| 7 | 2020 | 106 | |
| 8 | 2019 | 94 | |
| 9 | The promising role of tumor-associated macrophages in the treatment of cancer Hit paper breakdown → | 2024 | 93 |
| 10 | 2010 | 87 | |
| 11 | 2010 | 79 | |
| 12 | In vivo assembly enhanced binding effect augments tumor specific ferroptosis therapy Hit paper breakdown → | 2024 | 75 |
| 13 | 2018 | 68 | |
| 14 | 2022 | 67 | |
| 15 | 2021 | 65 | |
| 16 | 2023 | 63 | |
| 17 | 2017 | 59 | |
| 18 | 2020 | 56 | |
| 19 | 2018 | 55 | |
| 20 | 2017 | 52 |
About Wanhai Xu
Wanhai Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Biomedical Engineering and Cancer Research, having authored 134 papers that have together received 3.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (25 papers), Bladder and Urothelial Cancer Treatments (14 papers), Peptidase Inhibition and Analysis (13 papers), Prostate Cancer Treatment and Research (10 papers), Renal cell carcinoma treatment (9 papers), Epigenetics and DNA Methylation (7 papers), Nanoparticle-Based Drug Delivery (7 papers) and Cancer, Lipids, and Metabolism (7 papers). The work is most often cited by research in Biomaterials (659 citations), Cancer Research (614 citations), Molecular Biology (1.6k citations), Biomedical Engineering (868 citations) and Oncology (439 citations). Wanhai Xu has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Da‐Yong Hou, Hao Wang, Man‐Di Wang, Keliang Wang, Dong‐Bing Cheng, Zeng‐Ying Qiao, Hong‐Wei An, Hongtao Lu, Ziqi Wang and Xingjie Hu. Their work appears in journals such as Nature Communications, Advanced Materials, Small, Biomaterials and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.